C.S. Denlinger
C.S. Denlinger publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies and Cancer Treatment and Pharmacology.
- World rank
- #5,917,990 of 7,710,434 ranked researchers
- Rank in United States
- #1,450,170 of 1,627,098
- Works
- 20
- Citations
- 314
- Citations per work
- 15.7
What does C.S. Denlinger research?
C.S. Denlinger's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (19%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1367.1%
- Medicine1367.1%
- Life Sciences419.0%
- Everything else313.9%
- 1Oncology45% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Cancer Research14% of their works
- 4Molecular Biology5% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Surgery3% of their works
Research topics
Which keywords describe C.S. Denlinger's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Survival Analysis, Molecular Subtypes, Neoadjuvant Therapy, Breast Cancer, HER2 and Breast Tumours.
- Surgical Complications
- KRAS Mutations
- Targeted Therapy
- Gastric Cancer
- Endoscopic Resection
- Tumor Microenvironment
- Chemotherapy-Induced Peripheral Neuropathy
- Breast Tumours
- Breast Cancer
- Molecular Subtypes
- Clinical Practice Guidelines
- Chemotherapy
- Survival Analysis
- Neoadjuvant Therapy
- HER2
- Gene Expression
- Taxanes
- EGFR Mutations
- Fibroblast Activation Protein
- Immunosuppression
- Cetuximab
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Chemotherapy174 topics
- Clinical Practice Guidelines112 topics
- Survival Analysis112 topics
- Molecular Subtypes102 topics
- Neoadjuvant Therapy92 topics
- Breast Cancer81 topic
- HER281 topic
- Breast Tumours71 topic
- Gene Expression71 topic
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Taxanes61 topic
- Tumor Microenvironment62 topics
- EGFR Mutations41 topic
- Endoscopic Resection41 topic
- Fibroblast Activation Protein41 topic
- Gastric Cancer41 topic
- Immunosuppression41 topic
- Targeted Therapy41 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Pancreatic Cancer21 topic
- Surgical Complications21 topic
Where does C.S. Denlinger work?
C.S. Denlinger's main affiliation in the publication record is Fox Chase Cancer Center, United States.
How many publications and citations does C.S. Denlinger have?
OpenAlex counts 20 works and 314 citations for C.S. Denlinger, an h-index of 11, ranking #5,917,990 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about C.S. Denlinger. Posts are plain text and can be reported.